3.4.22.48	crystal structure determination of staphopain A in complex with inhibitor E64, folding pattern	
3.4.22.48	inactive mutant staphopain B in complex with inhibitor staphostatin B, 21°C, vapour diffusion method with sitting drops, reservoir solution: 2 M ammonium sulfate, 5% isopropanol, 0.8% v/v 1 M guanidinium hydrochloride, 1-2 weeks, cryoprotection in buffer containing a 9:1 mixture of 2.8 M ammonium sulfate and (2R,3R)-(-)-2,3-butanediol, injected into the drops, X-ray structure determination	
3.4.22.48	purified recombinant mature staphopain B, sitting drop vapour diffusion method at 4°C or 21°C, equal volume of protein solution containing 15 mg/ml protein in 5mM Tris, pH 7.5, and reservoir solution containing 50 mM Bis-Tris, pH 6.5, 20% w/v PEG 4000, or 100 mM HEPES, pH 7.5, 21% w/v PEG 4000, and 10% v/v 2-propanol, are mixed, a few weeks, X-ray diffraction structure determination and analysis at 2.5-2.8 A resolution	
3.4.22.48	staphopain A